You are here

Samsung Bioepis partners Takeda to develop original biotech drugs

Seoul

SAMSUNG Bioepis Co Ltd said on Monday that it will fund and develop multiple original drugs in partnership with Japan's Takeda Pharmaceutical Co Ltd, expanding its business scope beyond copies of existing biologic drugs.

Original biotech drugs represent a business ramp-up for

sentifi.com

Market voices on: